James E. Dentzer - 20 Mar 2026 Form 4 Insider Report for CURIS INC (CRIS)

Source evidence 5 source fields
Form type
4
Accepted by SEC
23 Mar 2026, 16:03:10 UTC
Previous filing
18 Mar 2026
Next filing
27 May 2026
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Diantha Duvall, Attorney-in-fact

Key filing fact

James E. Dentzer filed Form 4 for CURIS INC (CRIS) on 23 Mar 2026.

Key facts

  • This page summarizes James E. Dentzer's Form 4 filing for CURIS INC (CRIS).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 Mar 2026, 16:03.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001400977 Primary reporting owner

Dentzer James E

Relationship
President & CEO, Director
Address
128 SPRING STREET, BUILDING C - SUITE 500, LEXINGTON
Signature
/s/ Diantha Duvall, Attorney-in-fact
Signature date
23 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRIS transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+133,333
Change %
+866%
Price
Shares after
148,730
Date
20 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRIS transaction Derivative

Series B Convertible Preferred Stock

Conversion of derivative security

Transaction value
Shares
-100
Change %
-100%
Price
Shares after
0
Date
20 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
133,333
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each share of Series B Convertible Non-Redeemable Preferred Stock ("Series B Preferred Stock") automatically converted into 1,333.33 shares of Common Stock, for no additional consideration, at 5 p. m. Eastern Time on March 20, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series B Convertible Non-Redeemable Preferred Stock of Curis, Inc. (the "Certificate of Designations") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series B Preferred Stock was sold together with a Series A Warrant to purchase 1,333.33 shares of Common Stock, a Series B Warrant to purchase 1,333.33 shares of Common Stock and a Series C Warrant to purchase 1,333.33 shares of Common Stock (collectively, a "Security"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .